뒤로Cell Biology Exam 1: High-Yield Study Guide (Chapters 1–8)
스터디 가이드 - 스마트 노트
자료에 맞춘 맞춤형 노트, 핵심 정의, 예시, 맥락을 확장해 제공합니다.
Chapter 1: Stem Cells and Their Differentiation
Stem Cell Fate Decisions
Stem cells are unique cells capable of both self-renewal and differentiation. Their fate is tightly regulated by intrinsic and extrinsic factors, and disruptions in these controls can lead to disease or be harnessed for clinical applications.
Self-renewal: The process by which stem cells divide to produce more stem cells, maintaining the stem cell pool.
Differentiation: The process by which stem cells become specialized cell types.
Potency Hierarchy
Stem cells are classified by their potency, or the range of cell types they can produce.
Term | Can make | Example | Key fact |
|---|---|---|---|
Totipotent | Everything, including placenta | Zygote, 4-cell stage | Only the first few divisions |
Pluripotent | All body cells, NOT placenta | ESCs, iPSCs | Inner cell mass origin |
Multipotent | Multiple types, one lineage | HSCs, MSCs, NSCs | Most adult stem cells |
Unipotent | One cell type only | Myoblast → myocyte | Still capable of self-renewal |
Example: Hematopoietic stem cells (HSCs) are multipotent, giving rise to all blood cell types but not other tissues.
Stem Cell Source Comparison
ESC | Adult SC | iPSC | |
|---|---|---|---|
Source | Inner cell mass | Bone marrow, tissue niches | Reprogrammed somatic cells |
Potency | Pluripotent | Multipotent at best | Pluripotent |
Telomerase | High | Absent/low | Limited |
Rejection risk | High (foreign HLA) | Varies | None (autologous) |
Oncogenic risk | Low | Low | Elevated, c-Myc/retroviral insertion |
Ethics | Embryo destruction | None | None |
The Niche
Definition: The microenvironment that maintains stem cell properties through active signaling (e.g., Wnt, Notch, BMP antagonists).
Example: Lgr5+ intestinal stem cells require signals from adjacent Paneth cells.
Clinical Correlates
Metaplasia: Reversible replacement of one differentiated cell type by another, driven by stem cell reprogramming (e.g., Barrett esophagus: squamous → columnar).
Cancer stem cell hypothesis: Tumor regrowth is driven by a small, self-renewing subpopulation.
OSKM (Yamanaka) factors: Oct4, Sox2, Klf4, c-Myc reprogram somatic cells to iPSCs; c-Myc increases oncogenic risk.
Additional Testable Details
MAPK signaling: Promotes differentiation, opposes pluripotency.
STAT signaling: Supports pluripotency.
Wnt signaling: Promotes stemness in niche contexts.
Chromatin: Undifferentiated cells have open (euchromatin-rich) chromatin for broad transcriptional access.
Adherens junctions: E-cadherin/β-catenin anchor stem cells in the niche; loss leads to premature differentiation or cell loss.
microRNAs: Regulate both stemness and differentiation post-transcriptionally.
Chapter 2: Extracellular Matrix and Cell Adhesion
Core ECM Components
The extracellular matrix (ECM) is a dynamic structure providing support and signaling cues to cells. Defects in ECM components lead to characteristic diseases.
Component | Structure/Function | Disease when broken |
|---|---|---|
Fibrillar collagen (I, III) | Tensile strength; triple helix | Osteogenesis imperfecta |
Type IV collagen | Basement membrane meshwork | Alport syndrome, Goodpasture |
Type VII collagen | Anchoring fibrils, BM → dermis | Dystrophic epidermolysis bullosa |
Elastin + fibrillin | Elastic recoil | Marfan syndrome (FBN1) |
Proteoglycans/hyaluronan | Hydrated gel, compressive resistance, GF reservoir | Joint cartilage degeneration |
Fibronectin | Binds collagen, integrin, proteoglycan | Impaired wound scaffolding |
Laminin | Basement membrane backbone | Junctional epidermolysis bullosa |
Genetic ECM Disorders
Disorder | Gene/protein | Signature |
|---|---|---|
Marfan syndrome | FBN1 (fibrillin-1) | Long limbs/digits, aortic dilation, lens dislocation |
Ehlers-Danlos (classical) | COL5A1/COL5A2 | Hyperextensible skin, atrophic scarring |
Ehlers-Danlos (vascular) | COL3A1 | Arterial/organ rupture risk |
α1-antitrypsin deficiency | A1AT | Unchecked neutrophil elastase → emphysema |
Adhesion Structures
Junction | Transmembrane protein | Intracellular link | Disease |
|---|---|---|---|
Desmosome | Cadherins (Ca²⁺-dependent) | Intermediate filaments | Pemphigus |
Hemidesmosome | Integrins (α6β4) | Intermediate filaments | Bullous pemphigoid |
Focal adhesion | Integrins | Actin | n/a |
Adherens junction | Cadherins (E-cadherin) | Actin | Loss in cancer invasion |
Tight junction | Claudins, occludins | Actin | Claudin-16 mutation |
Gap junction | Connexins | None | Cardiac arrhythmia |
Collagen Synthesis and Related Deficiencies
Vitamin C: Required for prolyl/lysyl hydroxylase; deficiency causes scurvy.
Lysyl oxidase: Cross-links collagen/elastin; copper-dependent; defective in Menkes disease.
GAG sulfation: Most GAGs are sulfated except hyaluronic acid.
Adhesion Receptor Specifics
Integrins: Heterodimers; β2 subunit is leukocyte-specific.
Selectins: Mediate initial leukocyte rolling on endothelium.
Basement membrane assembly: Laminin assembles first, then recruits type IV collagen.
Chapter 3: Biological Membranes
Membrane Lipids
Lipid | Key features | Leaflet distribution | Clinical link |
|---|---|---|---|
Phospholipids | ~80% of lipid; amphipathic; glycerol backbone (except sphingomyelin) | Asymmetric, PS/PE inner, PC outer | PS externalization = apoptosis signal |
Cholesterol | Rigid steroid ring; buffers fluidity | Both leaflets equally | Statins ↓ cholesterol → ↑ fluidity |
Glycolipids | Sugar chains face extracellular only | Outer leaflet only | Blood group antigens, toxin receptors |
Membrane Asymmetry and Apoptosis
Flippases and floppases maintain phospholipid asymmetry.
During apoptosis, phosphatidylserine (PS) is externalized, signaling phagocytosis.
Membrane Fluidity
Increased unsaturated fatty acids: ↑ fluidity
Increased chain length: ↓ fluidity
Cholesterol: Buffers fluidity (↓ at high temp, ↑ at low temp)
Increased temperature: ↑ fluidity
Membrane Transport Types
Type | Direction vs. gradient | Energy | Example |
|---|---|---|---|
Simple diffusion | Down | None | O₂, CO₂ |
Facilitated diffusion | Down | None (protein-mediated) | GLUT transporters |
Primary active transport | Against | Direct ATP | Na⁺/K⁺-ATPase |
Secondary active transport | Against | Indirect (uses existing gradient) | Na⁺-glucose symporter |
Lipid Rafts and Caveolae
Lipid rafts: Cholesterol/sphingolipid-rich microdomains, concentrate signaling proteins.
Caveolae: Flask-shaped rafts formed by caveolin, involved in endocytosis and signaling.
Disruption impairs signal transduction, not passive diffusion.
Glycocalyx and Osmotic Balance
Glycocalyx: Carbohydrate coat for recognition, protection, signaling.
Body water: 50–60% of weight; extracellular fluid rich in Na⁺, Cl⁻.
Osmolality governs water distribution; osmotic shock can cause cell lysis.
Membrane Protein Mobility
Some proteins are anchored to the cytoskeleton, restricting movement.
FRAP measures protein mobility; slow recovery = restricted movement.
CFTR in cystic fibrosis: Folding/trafficking defect, not a lipid problem.
Chapter 4: The Cytoskeleton
The Three Filament Systems
Feature | Microfilaments (actin) | Intermediate filaments | Microtubules |
|---|---|---|---|
Diameter | ~8 nm | ~10 nm | ~25 nm |
Subunit | G-actin | Keratins, vimentin, etc. | α/β-tubulin dimer |
Polarity | Yes | No | Yes |
Energy for assembly | ATP | None | GTP |
Primary role | Contraction, motility | Mechanical strength | Transport, mitosis |
Motor protein | Myosin | None | Kinesin, Dynein |
Actin Dynamics
Polymerizes by adding ATP-G-actin; ATP hydrolysis destabilizes subunits, favoring depolymerization at the minus end.
Treadmilling: Plus end grows, minus end shrinks at equal rates.
Protein | Function |
|---|---|
Profilin | Promotes polymerization |
Cofilin | Severs filaments |
Arp2/3 | Nucleates new filaments, branching |
Tropomyosin | Stabilizes filaments |
Phalloidin | Stabilizes filaments (lab tool) |
Gelsolin | Severs/caps filaments (Ca²⁺-regulated) |
Motor Proteins
Motor | Direction | Analogy |
|---|---|---|
Kinesin | Toward (+) end (anterograde) | Away from cell center |
Dynein | Toward (−) end (retrograde) | Toward cell center |
Intermediate Filament Types
Type | Protein | Location | Disease example |
|---|---|---|---|
I/II | Keratins | Epithelial cells | Epidermolysis bullosa simplex |
III | Vimentin | Mesenchymal cells | n/a |
III | Desmin | Muscle | Desminopathy |
III | GFAP | Astrocytes | Alexander disease |
IV | Neurofilaments | Neurons | n/a |
V | Lamins | Nuclear envelope | Progeria |
Microtubule Dynamic Instability
Microtubules grow/shrink via GTP cap; loss of cap triggers rapid depolymerization (catastrophe).
Drugs: Colchicine/vinca alkaloids block polymerization; Taxol stabilizes microtubules, blocking disassembly.
RBC Membrane Skeleton
Spectrin network cross-linked to actin, anchored via ankyrin and protein 4.1.
Defects cause hereditary spherocytosis (fragile, spherical RBCs).
Ciliary Structure
Motile cilia: 9+2 axoneme, powered by dynein.
Primary cilia: 9+0, sensory, lack central pair.
Defects: Primary ciliary dyskinesia (motile), PKD (primary cilia, mechanosensing).
Cytoskeletal Disease Beyond Filament Structure
Duchenne muscular dystrophy: Dystrophin links actin to ECM; loss destabilizes muscle membrane.
All cytoskeletal systems are integrated, not independent.
Chapter 5: The Organelles
The Nucleolus
Site of rRNA synthesis and ribosome assembly; organized around NORs on acrocentric chromosomes.
Protein Targeting to the ER
SRP recognizes N-terminal signal, halts translation, docks ribosome at ER.
Defects in SRP impair ER targeting, not glycosylation.
The Protein-Processing Chain
Organelle | Core function | Key modification |
|---|---|---|
Rough ER | Synthesis/folding of secreted, membrane, lysosomal proteins | N-linked glycosylation, disulfide bonds, BiP/GRP78 folding |
Smooth ER | Lipid synthesis, detox, Ca²⁺ storage | Cytochrome P450 metabolism |
Golgi | Sort, modify, package | O-linked glycosylation, M6P tagging, proteolytic processing |
Mitochondria | ATP generation | Own DNA, double membrane |
Lysosome | Degradation | Acid hydrolases, pH ~5 |
Peroxisome | Fatty acid/purine breakdown, H₂O₂ detox | Formed from ER, enzymes from free ribosomes |
Lysosomal Storage Diseases
Disease | Deficient enzyme | Accumulated substrate | Clinical signature |
|---|---|---|---|
Tay-Sachs | β-hexosaminidase A | GM2 ganglioside | Neurodegeneration, cherry-red macula |
Gaucher (type I) | Glucocerebrosidase | Glucocerebroside | Hepatosplenomegaly, bone pain |
Gaucher (type II) | Glucocerebrosidase | Glucocerebroside | Severe neurological, early death |
Hurler/Hunter | GAG-degrading hydrolases | Glycosaminoglycans | Coarse facies, CNS/hearing damage |
Farber | Acid ceramidase | Ceramide | Fatal in first year |
I-cell disease | N/A (trafficking defect) | Multiple | Enzymes secreted, not delivered |
Mitochondrial Genetics
Maternal inheritance; heteroplasmy explains variable expressivity.
High-energy tissues most affected (e.g., muscle, CNS).
Examples: Leber hereditary optic neuropathy, Pearson syndrome.
Peroxisomal Disease
X-linked adrenoleukodystrophy: Impaired very-long-chain fatty acid breakdown.
Zellweger syndrome: Defective peroxisomal protein import.
Lysosomal Acidification and Pharmacology
v-ATPases maintain acidic pH (~5); chloroquine raises pH, disrupting function.
ER Stress and the Unfolded Protein Response
UPR reduces global protein synthesis to allow chaperones to catch up.
Autophagy and Apoptosis Signals
Autophagosomes deliver damaged organelles to lysosomes for degradation.
Cytochrome c release from mitochondria triggers intrinsic apoptosis pathway.
Chapters 6 & 7: Eukaryotic Genomes and DNA Replication
Chromatin Packaging Hierarchy
DNA (2 nm) → nucleosome (~10 nm) → 30 nm fiber → loop domains → chromosome.
Euchromatin: Dispersed, active, early S phase replication.
Heterochromatin: Condensed, silent, late S phase replication.
Constitutive heterochromatin: Always silent (centromeres, telomeres).
Facultative heterochromatin: Reversibly silent (e.g., Barr body).
Epigenetic Regulation
Mechanism | Enzyme | Effect |
|---|---|---|
Histone acetylation | HAT/HDAC | Opens chromatin |
Histone/DNA methylation | HMT, DNMT1 | Condenses chromatin, silencing |
DNA Replication: Enzymes and Steps
Feature | Leading strand | Lagging strand |
|---|---|---|
Primer synthesis | Pol α/primase (once) | Pol α/primase (per Okazaki fragment) |
Synthesis direction | Continuous | Discontinuous |
Main polymerase | Pol ε | Pol δ |
Primer removal | n/a | FEN1 + RNase H |
Joining | n/a | DNA ligase |
PCNA: Sliding clamp for processivity.
Topoisomerase: Relieves supercoiling.
SSBs: Prevent premature reannealing.
Genome Composition and Repetitive DNA
~1.5% protein-coding; rest is regulatory and repetitive DNA.
LINEs/SINEs: Largest fraction of repeats.
Satellite DNA: Centromeres/telomeres; alpha satellite DNA for centromere function.
Trinucleotide repeat expansions: Cause anticipation in diseases like Huntington's.
The Telomere Problem and Solution
End-replication problem: Lagging strand can't fully replicate 3′ end.
Telomerase: RNA-dependent DNA polymerase extends 3′ overhang.
Active in stem cells, germ cells, most cancers.
DNA Repair Overview
Damage type | Repair pathway | Disease if defective |
|---|---|---|
Damaged single bases | Base excision repair (BER) | C→T transition mutations |
UV-induced dimers | Nucleotide excision repair (NER) | Xeroderma pigmentosum |
Base mismatches | Mismatch repair (MMR) | Lynch syndrome |
Double-strand breaks | MRN complex, HR/NHEJ | BRCA-mutant cancers, ataxia telangiectasia |
HR: High-fidelity, uses sister chromatid.
NHEJ: Fast, error-prone, no template.
PARP inhibitors: Exploit synthetic lethality in BRCA-deficient cells.
Chapter 8: Transcription
The Three RNA Polymerases
Polymerase | Location | Transcribes | Key feature |
|---|---|---|---|
RNA Pol I | Nucleolus | rRNA (large subunits) | Requires UBF; highest rate |
RNA Pol II | Nucleoplasm | All protein-coding genes, most snRNA | Unique CTD for processing |
RNA Pol III | Nucleoplasm | tRNA, 5S rRNA, small RNAs | Internal promoters |
Prokaryotic vs. Eukaryotic Transcription
Feature | Prokaryotic | Eukaryotic |
|---|---|---|
Compartmentalization | Coupled transcription/translation | Separated by nuclear envelope |
RNA processing | Minimal | Extensive (cap, splice, poly-A) |
mRNA structure | Polycistronic | Monocistronic |
Ribosome | 70S | 80S |
Translation initiation | Shine-Dalgarno | 5′ cap recognition |
Operons | Present | Absent |
Promoter Recognition and Initiation
TATA box (~25–30 bp upstream) is bound by TFIID (TBP subunit).
TFIIH unwinds DNA and phosphorylates Pol II CTD to initiate elongation.
CTD phosphorylation status coordinates transcription and processing.
mRNA Processing Steps
5′ capping: 7-methylguanosine cap added co-transcriptionally; required for translation initiation and stability.
Splicing: Spliceosome removes introns (GU...AG boundaries); alternative splicing allows multiple isoforms.
Cleavage and polyadenylation: ~200 adenine poly(A) tail added at 3′ end; protects from degradation, regulates translation.
Post-Translational Modification Location Map
Location | Modification | Function/Disease |
|---|---|---|
Rough ER lumen | N-linked glycosylation, disulfide bonds | CDG |
Golgi | O-linked glycosylation, M6P tagging, cleavage | I-cell disease |
Cytoplasm/nucleus | Phosphorylation, acetylation, ubiquitination, methylation | Signaling, chromatin regulation, proteasomal targeting |
Transcriptional Regulation
Transcription factors have DNA-binding and transactivation domains.
Chromatin accessibility (nucleosome positioning, histone marks, DNA methylation) regulates promoter access.